February 27, 2023
COVID-19 treatments advanced in the Japan drug sales ranking in 2022, with Gilead Sciences’ Veklury (remdesivir) joining the top 10 list for the first time, at fifth, according to data released by IQVIA on February 24. Veklury, which became available...read more